Crystal's Coder HubModifier -JW: Drug Amount Discarded/Not Administered to Any Patient
Quick reference
- What it signals: -JW is appended to a HCPCS drug code to report the quantity of a single-dose container drug or biological that was discarded/wasted and not administered to any patient — enabling the provider to receive reimbursement for the discarded amount.
- Companion modifier -JZ: Effective July 1, 2023, CMS requires -JZ on all single-dose container drug claims where there is zero waste (full dose was administered). Together, -JW (waste exists) and -JZ (no waste) are now mandatory for all separately payable single-dose drug claims on Medicare Part B. Do not use one without the other being on the claim in the correct context.
- Single-dose only: -JW and -JZ apply only to single-dose containers (vials, prefilled syringes, packages) based on FDA-approved labeling. Multi-dose vials are excluded from this requirement.
Core Medicare/CMS rules (high yield)
- Mandatory as of July 1, 2023: CMS Transmittal 12067 (CR 13056) made -JW and -JZ required on all Medicare Part B and outpatient facility (CMS-1450) claims for single-dose drugs. Claims submitted without one or the other may be subject to audit.
- Two-line billing when waste exists: When a portion of a single-dose vial is discarded, bill on two separate claim lines:
- One-line billing when no waste: When the entire contents of the single-dose container are administered, bill on one line: HCPCS drug code + -JZ + total units administered.
- Overfill excluded: CMS confirmed that overfill (medication exceeding the labeled amount, such as extra volume in a prefilled syringe) is not billable with -JW. Do not bill for overfill waste.
- Samples and white-bagged drugs excluded: Drugs provided as samples or via specialty/white-bag pharmacy arrangements are not eligible for -JW billing — the provider did not purchase them.
- Commercial payers: -JW/-JZ are Medicare-specific requirements tied to CMS drug rebate tracking. Most commercial payers (BCBS, UHC, Aetna, Cigna) do not currently require -JW or -JZ.
- NDC requirement: CMS and many MACs require a valid National Drug Code (NDC) to be reported alongside the HCPCS drug code on the claim line. Confirm your MAC’s specific NDC reporting requirements.
Documentation checklist (what to show)
- Discarded amount documented in the medical record: CMS requires that the discarded drug quantity be documented in the patient’s medical record (MAR, nursing note, or administration record) on the date of service.
- Administered dose documented separately: The record must show the amount actually administered to the patient, supporting the units billed on Line 1.
- Single-dose labeling confirmed: Confirm the vial/package is FDA-labeled as single-dose (not multi-dose) before applying -JW/-JZ.
- No rounding up: Units are reported in whole numbers (no decimal points). If the waste is less than one billable unit (e.g., 0.02 mg when 1 unit = 0.1 mg), report only -JZ on one line — there is no separately billable waste.
Common drug HCPCS codes billed with -JW (specialty-specific examples)
Note: The HCPCS drug J-code is wikilinkable if it is a valid, separately payable code. Below are examples — always verify unit definitions for each code.
- Intravitreal injections (Ophthalmology):
- J0178 (aflibercept/Eylea) — 1 mg; prefilled syringe, single-dose; -JZ typically (no waste when full dose given from prefilled syringe).
- J2778 (ranibizumab/Lucentis) — 0.1 mg; single-dose vial; -JW if partial vial discarded.
- J3396 (bevacizumab/Avastin compounded) — 0.25 mg; single-dose drawn syringe; -JW if any waste.
- Oncology/Infusion examples:
- Large-molecule biologicals drawn from single-dose vials (e.g., trastuzumab, pembrolizumab) frequently generate -JW waste due to weight-based dosing leaving residual in the vial.
- Rheumatology/Infusion examples:
- Single-dose infusion biologicals (e.g., tocilizumab, abatacept) with weight-based dosing — -JW for residual waste from single-dose vials.
Billing line examples
| Line | HCPCS | Modifier | Units | Description |
|---|---|---|---|---|
| 1 | J0178 | -JZ | 2 | Aflibercept 2 mg administered (full dose from prefilled syringe, no waste) |
| 1 | J2778 | (none) | 3 | Ranibizumab 0.3 mg administered (units given to patient) |
| 2 | J2778 | -JW | 2 | Ranibizumab 0.2 mg discarded from single-dose vial |
Payer considerations
- Medicare Part B (professional and HOPD): -JW and -JZ are both mandatory for single-dose container drugs as of July 1, 2023. Non-compliance = audit risk.
- Medicare Advantage/Part C: Many MA plans follow CMS guidance but may have delayed implementation timelines. Verify plan-specific policy.
- Wisconsin Medicaid / State Medicaid: Verify ForwardHealth drug waste billing guidance — state Medicaid programs may or may not require -JW.
- Commercial (BCBS, UHC, Aetna, Cigna): Currently not required by most commercial payers. Adding it won’t typically cause a denial, but it may be ignored for processing purposes.
Quick self-check (before you append -JW)
- Is the drug from a single-dose container (FDA-labeled as single-dose)?
- Was a portion of the drug discarded and not administered to any patient?
- Are you billing the administered amount on Line 1 (no -JW) and the discarded amount on Line 2 with -JW?
- Is the discarded amount ≥1 billable unit (whole number — no decimals)? If <1 unit, use -JZ on a single line instead.
- Is the discard documented in the medical record?
- Is this a Medicare claim (not a commercial payer that doesn’t require it)?